Exposure to glyphosate-based herbicides and risk for non-Hodgkin lymphoma: a meta-analysis and supporting evidence

L Zhang, I Rana, RM Shaffer, E Taioli… - … Research/Reviews in …, 2019 - Elsevier
Glyphosate is the most widely used broad-spectrum systemic herbicide in the world. Recent
evaluations of the carcinogenic potential of glyphosate-based herbicides (GBHs) by various …

Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting

MA Rahim, N Jan, S Khan, H Shah, A Madni, A Khan… - Cancers, 2021 - mdpi.com
Simple Summary Cancer is one of the leading causes of death globally. Several studies,
efforts and treatment strategies have been put forth for the treatment of different types of …

Annual report to the nation on the status of cancer, 1975–2014, featuring survival

A Jemal, EM Ward, CJ Johnson… - JNCI: Journal of the …, 2017 - academic.oup.com
Abstract Background The American Cancer Society (ACS), the Centers for Disease Control
and Prevention (CDC), the National Cancer Institute (NCI), and the North American …

Recessions, healthy no more?

CJ Ruhm - Journal of health economics, 2015 - Elsevier
Abstract Over the 1976–2010 period, total mortality shifted from strongly procyclical to being
weakly or unrelated to macroeconomic conditions. The association is likely to be poorly …

[HTML][HTML] Delivering safer immunotherapies for cancer

L Milling, Y Zhang, DJ Irvine - Advanced drug delivery reviews, 2017 - Elsevier
Cancer immunotherapy is now a powerful clinical reality, with a steady progression of new
drug approvals and a massive pipeline of additional treatments in clinical and preclinical …

Fucoidan and cancer: A multifunctional molecule with anti-tumor potential

F Atashrazm, RM Lowenthal, GM Woods, AF Holloway… - Marine drugs, 2015 - mdpi.com
There is a wide variety of cancer types yet, all share some common cellular and molecular
behaviors. Most of the chemotherapeutic agents used in cancer treatment are designed to …

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic …

J Deckert, MC Wetzel, LM Bartle, A Skaletskaya… - Clinical Cancer …, 2014 - AACR
Purpose: The CD38 cell surface antigen is expressed in diverse hematologic malignancies
including multiple myeloma, B-cell non-Hodgkin lymphoma (NHL), B-cell chronic …

Racial differences in three major NHL subtypes: descriptive epidemiology

Y Li, Y Wang, Z Wang, D Yi, S Ma - Cancer epidemiology, 2015 - Elsevier
Background NHL (non-Hodgkin lymphoma) consists of over 60 subtypes, ranging from slow-
growing to very aggressive. The three largest subtypes are DLBCL (diffuse large B-cell …

Leptomeningeal metastasis: a review of the pathophysiology, diagnostic methodology, and therapeutic landscape

A Nguyen, A Nguyen, OT Dada, PD Desai, JC Ricci… - Current …, 2023 - mdpi.com
The present review aimed to establish an understanding of the pathophysiology of
leptomeningeal disease as it relates to late-stage development among different cancer …

Leveraging heterogeneity in systemic lupus erythematosus for new therapies

ME Allen, V Rus, GL Szeto - Trends in molecular medicine, 2021 - cell.com
Systemic lupus erythematosus (SLE) is a multisystem, chronic autoimmune disease where
treatment varies by patient and disease activity. Strong preclinical results and clinical …